Bioeconomy Capital - aVenture Asset Manager Research
Bioeconomy Capital
Operating Status: Operating
Bioeconomy Capital: An investment fund accelerating the biotech revolution with strategic, early-stage investments.
Location
Seattle, WA, US
Founded
2015
Bioeconomy Capital is an investment firm focused on accelerating the biotechnology revolution through strategic, early-stage investments. The firm primarily invests in Seed, Series A, and Series B rounds, leveraging its extensive operational expertise and product development experience to support the growth of its portfolio companies. Bioeconomy Capital's investments are designed to build and deploy technological capabilities that will form the critical infrastructure of the 21st-century economy.
Notable portfolio companies include Arzeda, Lumen Bioscience, MicroByre, Parse Biosciences, Riffyn, RoosterBio, and Tandem PV. The firm's investment philosophy centers on a proprietary blueprint derived from five decades of combined experience among its fund managers. This blueprint emphasizes strategic analysis and operational support, providing portfolio companies with unique value-add services that enhance their growth and development in the biotech sector.
Bioeconomy Capital - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages